PBYI
NASDAQStockPuma Biotechnology, Inc.
$5.91-0.09 (-1.50%)
52-Week Range
$2.74
$7.68
Key Stats
Market Cap
300.7M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.27
Volume
142.5K
Avg Volume
555.0K
Performance
1M
-11.45%
3M
+1.03%
6M
+26.72%
YTD
+1.91%
1Y
+76.05%
3Y
+140.98%
5Y
-49.22%
Price Chart
ETF Exposure
PBYI is held by 46 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| LITL | Simplify Piper Sandler US Small-Cap PLUS Income ETF | 0.71% |
| FDM | First Trust Dow Jones Select MicroCap Index Fund | 0.33% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.30% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.26% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.18% |
| EES | WisdomTree U.S. SmallCap Fund | 0.06% |
| STSB | iShares Factors US Small Blend Style ETF | 0.06% |
| IWC | iShares Micro-Cap ETF | 0.05% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.04% |
| AVUV | Avantis U.S. Small Cap Value ETF | 0.04% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.04% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.03% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.02% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.02% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.02% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| DFSV | Dimensional - US Small Cap Value ETF | 0.01% |
| DFAT | Dimensional - US Targeted Value ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
About PBYI ETF Exposure
Puma Biotechnology, Inc. (PBYI) is held by 46 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 300.7M, PBYI is a widely held institutional stock. The stock currently trades at $5.91. Investors can gain exposure to PBYI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PBYI, sorted by portfolio weight.